Your session is about to expire
← Back to Search
Neuropeptide Y for High Blood Pressure (OB-HTN Trial)
OB-HTN Trial Summary
This trial will help researchers understand how the nervous system communicates with blood vessels to increase blood pressure during stress, and how hypertension and obesity may influence this process.
OB-HTN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOB-HTN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 18 Patients • NCT02639637OB-HTN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 55 years old with a BMI under 30.People with diabetes are not allowed in the study.If you are between the ages of 18 and 55 and have high blood pressure, you may not be eligible if you are not obese, or if your body mass index (BMI) is less than 30.I am between 18-55, have a BMI over 30, and diagnosed with high blood pressure.I have a significant heart condition.I am 18-55 years old, have a BMI under 30, and my high blood pressure was confirmed by a 24-hour monitor.I have kidney disease.You have a history of smoking.I am between 18 and 55 years old with a BMI over 30.I am between 18 and 55 years old with a BMI under 30.
- Group 1: Hypertensive
- Group 2: Obese
- Group 3: Obese-hypertensive
- Group 4: Healthy Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies available in this medical trial at present?
"As confirmed on clinicaltrials.gov, this medical experiment is actively looking for potential participants. The research was initially published on July 18th 2021 and most recently updated on August 8th 2022."
Am I a viable candidate to participate in this research?
"This clinical trial requires 100 individuals aged 18-55 that fit into four different categories: Control (BMI<30), Hypertensive (BMI<30, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring) , Obese (BMI>30), and Obese-Hypertensive (BMI>30 with a diagnosis of hypertension by 24 hour ambulatory blood pressure monitoring)."
What other research has employed Neuropeptide Y as its focus?
"At present, there is one ongoing clinical trial pertaining to Neuropeptide Y. This research does not have any Phase 3 trials running and the majority of testing is taking place in Dallas, Texas with a single other location involved as well."
How many participants are being included in this research project?
"Affirmative. Clinicaltrials.gov has verified that this clinical trial, which was first published on July 18th 2021, is still actively recruiting patients at the moment. It is estimated that 100 people need to be enrolled from 1 medical centre in order for the study to move forward."
Is the geriatric population being considered for involvement in this trial?
"The parameters for this trial necessitate that potential participants are aged between 18 and 55. If candidates do not meet these criteria, there exist 252 studies available to those under 18 years old or 1236 for elderly individuals over 65."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Texas Southwestern Medical Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger